Biogen Inc. (BIIB) short interest & options flow
NASDAQBIIB upgraded to Buy by Argus Research with $280 price target, as analyst wave accelerates. Stock at $249.65, up 2.3% today. Consensus target now $263.60, with 21 Buy ratings vs 10 Holds. Short interest easing to 3.8% of float.
- Market cap
- $37.49B
- Next earnings
- 5 Feb 2027
Key data as of 3 Nov 2026
Latest signals on BIIB
- Analyst
BIIB upgraded to Buy by Argus Research with $280 price target, as analyst wave accelerates. Stock at $249.65, up 2.3% today. Consensus target now $263.60, with 21 Buy ratings vs 10 Holds. Short interest easing to 3.8% of float.
2 Analyst updates in 30 days
BIIB news and analysis
RSSNo long-form analysis yet for BIIB. Pulse alerts and the live data picture are available on ORTEX.
Open BIIB on ORTEX →Want the live picture for BIIB?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BIIB — free to start on ORTEX.
Sign up for free →Open BIIB on ORTEX